26202 Federal Register / Vol. 87, No. 85 / Tuesday, May 3, 2022 / Notices 

comments on understandability of the 

standards, suggested changes, and 

usefulness of the draft standards to 

industry and agencies. 

Guiding questions in standard 

development include: 

• Do the draft business standards 

appropriately document the business 

processes covered? 

• Are the draft business standards 

easy to understand? 

• Will your organization be able to 

show how your solutions and/or 

services can meet these draft business 

standards? 

• What would you change about the 

draft business standards? Is there 

anything missing? 

Comments will be used in 

formulation of the final business 

standards. 

Krystal J. Brumfield, 

Associate Administrator, Office of 

Government-wide Policy, General Services 

Administration. 

[FR Doc. 2022–09423 Filed 5–2–22; 8:45 am] 

BILLING CODE 6820–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–CK–21–001SUPP, US Travelers 

Health Research, Surveillance, 

Communication and Outreach Network. 

Date: June 3, 2022. 

Time: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference, Centers for 

Disease Control and Prevention, Room 

1080, 8 Corporate Square Boulevard, 

Atlanta, Georgia 30329. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, 1600 Clifton Road 

NE, Mailstop US8–1, Atlanta, Georgia 

30329–4027, (404) 718–8833, 

ganderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–09494 Filed 5–2–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panels 

(SEP)—CDC–RFA–CK22–2204, US 

Public Health Pathogens Genomics 

Centers of Excellence. 

Dates: July 27–28, 2022 

Times: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference, Centers for 

Disease Control and Prevention, Room 

1080, 8 Corporate Square Boulevard, 

Atlanta, Georgia 30329. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, 1600 Clifton Road 

NE, Mailstop US8–1, Atlanta, Georgia 

30329–4027, (404) 718–8833, 

ganderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–09493 Filed 5–2–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Healthcare Infection Control 

Practices Advisory Committee 

(HICPAC). This virtual meeting is open 

to the public, limited only by the 

number of audio and web conference 

lines (300 audio and web conference 

lines are available). Time will be 

available for public comment. 

Registration is required. 

DATES: The meeting will be held on June 

2, 2022, from 12:00 p.m. to 2:30 p.m., 

EDT. 

ADDRESSES: To register for this web 

conference, please go to: www.cdc.gov/ 

hicpac. All registered participants will 

receive the meeting link and 

instructions shortly before the meeting. 

Please click the link below to join the 

webinar: https://cdc.zoomgov.com/ 


lotter on DSK11XQN23PROD with NOTICES1